University · founded 1963
Icahn School of Medicine at Mount Sinai
New York, United States · icahn.mssm.edu
Part of Mount Sinai Health System
- Citations, last 5 years
- 513.8k
- Works, last 5 years
- 56.9k
- h-index
- 1,324
- Scientists listed
- 2 724
- Grants since 2016
- 7 219
Grants received
2018–2023 · career development · K23
Mentalizing deficits in cocaine addiction, associations with immune dysregulation and childhood maltreatment
Keren Bachi · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Habenular immune signaling and addiction
Paul J. Kenny · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2020 · research · R21
A Transgenic System for Targeted Ablation of Reproductive and Maternal-Effectgenes
Florence Louise Marlow · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Computational and Neural Modeling of Cue Reactivity in Addiction
Xiaosi Gu · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R33
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
Joseph E Finkelstein · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2022 · research · R01
Regulation of Skeletal Growth by Soft Tissue Extracellular Matrix
Dirk Hubmacher · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · career development · K08
The Role of KIBRA Signaling in Podocyte Injury
Kristin Meliambro · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2020 · research · R21
Circulating microRNAs in extracellular vesicles, household air pollution and lung development in Ghana
Darby Jack · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · cooperative agreement · U01
Improving Medication Adherence in adolescents who had a Liver Transplant: iMALT
Eyal Shemesh · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2022 · research · R00
Determining the Neurodevelopmental Effects of Transition from Breastfeeding to Infant Formula using a Novel Biomarker
Christine Austin · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2022 · research · R01
Preventing CD4+ T memory cells from becoming HIV reservoirs
Viviana A Simon · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Myeloid Specific Targeted Nanoimunotherapy for Organ Transplant Acceptance
Jordi Ochando · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2020 · research · R56
Rapid and Long-Lasting Antidepressant Action by Targeting Midbrain HCN Channels
Ming-Hu Han · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · career development · K23
Elucidation of the role of human genetic factors underlying viral myocarditis susceptibility
Amy R. Kontorovich · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Dissect governing factors for tumor stem cell dormancy in biomimetic vascular/GBM model
Guohao Dai · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R33
Comprehensive Health Informatics Engagement Framework for Pulmonary Rehab
Joseph E Finkelstein · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2022 · cooperative agreement · U19
Fluomics: The Next Generation
Adolfo Garcia-Sastre · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Electrophysiological Markers for Interventions in Phelan-McDermid Syndrome and Idiopathic Autism
Alexander Kolevzon · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · RF1
SYSTEMATIC DRUG REPURPOSING TARGETING IMMUNE ACTIVATION NETWORKS IN ALZHEIMER'S DISEASE (AD)
Michelle E Ehrlich · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Epigenetic Control of Human Beta Cell Proliferation
Carmen Argmann · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · RF1
Age-related Tauopathy in HIV-associated Neurocognitive Disorders
John Fonda Crary · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · career development · K23
Elucidation of the role of human genetic factors underlying viral myocarditis susceptibility
Amy R. Kontorovich · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · career development · K07
Population Based Research in Geriatric Palliative Care
Melissa Diane Aldridge · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2024 · research · R56
Interferon-beta trans-signaling in transplant
Miguel Fribourg · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Systems modeling of shared and distinct molecular mechanisms underlying comorbid Major Depressive Disorder and Alzheimer's disease
Michelle E Ehrlich · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2019 · career development · K99
Intrauterine Metal Exposure, Placental Gene Networks and Fetal Growth
Maya Ariane Deyssenroth · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2028 · research · R35
Wnt/Frizzled-PCP signaling in development and disease
Marek Mlodzik · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Interferon-beta in transplant
Miguel Fribourg · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2020 · research · R21
Application of intein-based chemical methods to directly manipulate neuronal histone modifications in rodent models of addiction
Yael E David-Shternberg · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Novel Selective Type II kinase Inhibitors to treat Diabetes
Robert J Devita · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Novel Selective Type II kinase Inhibitors to treat Diabetes
Robert J Devita · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · cooperative agreement · UH3
Development of novel therapeutics for opioid dependence
Theodore M Kamenecka · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Identification of novel pathogenic tandem repeat expansions using long read sequencing
Andrew James Sharp · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · training · T32
Training Program in Cancer Prevention and Control for Priority Populations
Guy H Montgomery · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Cardiomyocyte-specific modified mRNA of Pkm2 for induction of cardiac regeneration in ischemic heart failure
Lior Zangi · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018 · research · Inflammation Biomarkers Program
Using Changes in Immune Cells to Diagnose or Track Parkinson's Disease
Towfique Raj · Icahn School of Medicine at Mount Sinai · funded by Michael J. Fox Foundation for Parkinson's Research
2018–2023 · career development · K08
Astrocytic control of lymphocyte migration and differentiation in CNS inflammatory lesions
Sam H Horng · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2023 · research · R01
Assessment of Policies through Prediction of Long-term Effects on Cardiovascular Disease Using Simulation (APPLE CDS)
Yan Li · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018–2020 · research · R03
Paid Caregiving Among Persons with Dementia: Patient and Family Caregiver Outcomes
Jennifer M Reckrey · Icahn School of Medicine at Mount Sinai · funded by National Institutes of Health
2018 · grant · Prevention
The MELODY Trial: Modulating Early Life Microbiome through Dietary Intervention in Crohn's Disease
Icahn School of Medicine at Mount Sinai · funded by Leona M. and Harry B. Helmsley Charitable Trust
